Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease, and normals

S. I. Deutsch, R. C. Mohs, M. I. Levy, A. B. Rothpearl, D. Stockton, T. Horvath, A. Coco, K. L. Davis

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Acetylcholinesterase (AChE) activity and protein were measured in the CSF of patients with Alzheimer's disease, depression, schizophrenia with and without tardive dyskinesia, and control subjects. AChE activity was assayed by a radioenzymatic method involving the direct extraction of hydrolyzed 3H-acetate into a toluene-based scintillation fluid followed by liquid scintillation spectrometry. AChE activity was proportional to the amount of CSF protein. Greater than 90% of AChE activity in CSF could be inhibited by 10-3 M eserine. In addition, activity remained stable despite repeated freeze-thawing in an acetone-dry ice bath. Age was found to be positively correlated with CSF protein and AChE activity expressed per volume CSF, but not with AChE measured per milligram protein. No differences between diagnostic groups were found on either measure of AChE when the extraneous factors of age and CSF protein concentrations were controlled, or were any differences found between groups for CSF protein when age was controlled.

Original languageEnglish
Pages (from-to)1363-1373
Number of pages11
JournalBiological Psychiatry
Issue number12
StatePublished - 1983


Dive into the research topics of 'Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease, and normals'. Together they form a unique fingerprint.

Cite this